Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Second Sight Medical Products stock | $2.88

Learn how to easily invest in Second Sight Medical Products stock.

Second Sight Medical Products Inc is a medical devices business based in the US. Second Sight Medical Products shares (EYES) are listed on the NASDAQ and all prices are listed in US Dollars. Second Sight Medical Products employs 11 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Second Sight Medical Products

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EYES – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Second Sight Medical Products stock price (NASDAQ: EYES)

Use our graph to track the performance of EYES stocks over time.

Second Sight Medical Products shares at a glance

Information last updated 2021-10-16.
Latest market close$2.88
52-week range$0.72 - $20.00
50-day moving average $3.34
200-day moving average $4.96
Wall St. target price$2.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.33

Buy Second Sight Medical Products shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Second Sight Medical Products stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Second Sight Medical Products price performance over time

Historical closes compared with the close of $2.88 from 2021-10-18

1 week (2021-10-09) N/A
1 month (2021-09-20) -10.56%
3 months (2021-07-20) -25.19%
6 months (2021-04-20) -60.76%
1 year (2020-10-20) 231.07%
2 years (2019-10-18) 238.82%
3 years (2018-10-19) 83.44%
5 years (2016-10-20) 2.89

Second Sight Medical Products financials

Revenue TTM $497,000
Gross profit TTM $500,000
Return on assets TTM -12.41%
Return on equity TTM -21.65%
Profit margin 0%
Book value $1.83
Market capitalisation $115.1 million

TTM: trailing 12 months

Shorting Second Sight Medical Products shares

There are currently 2.2 million Second Sight Medical Products shares held short by investors – that's known as Second Sight Medical Products's "short interest". This figure is 6.8% down from 2.3 million last month.

There are a few different ways that this level of interest in shorting Second Sight Medical Products shares can be evaluated.

Second Sight Medical Products's "short interest ratio" (SIR)

Second Sight Medical Products's "short interest ratio" (SIR) is the quantity of Second Sight Medical Products shares currently shorted divided by the average quantity of Second Sight Medical Products shares traded daily (recently around 1.0 million). Second Sight Medical Products's SIR currently stands at 2.08. In other words for every 100,000 Second Sight Medical Products shares traded daily on the market, roughly 2080 shares are currently held short.

However Second Sight Medical Products's short interest can also be evaluated against the total number of Second Sight Medical Products shares, or, against the total number of tradable Second Sight Medical Products shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Second Sight Medical Products's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Second Sight Medical Products shares in existence, roughly 60 shares are currently held short) or 0.0828% of the tradable shares (for every 100,000 tradable Second Sight Medical Products shares, roughly 83 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Second Sight Medical Products.

Find out more about how you can short Second Sight Medical Products stock.

Second Sight Medical Products share dividends

We're not expecting Second Sight Medical Products to pay a dividend over the next 12 months.

Have Second Sight Medical Products's shares ever split?

Second Sight Medical Products's shares were split on a 1:8 basis on 5 January 2020. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Second Sight Medical Products shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Second Sight Medical Products shares which in turn could have impacted Second Sight Medical Products's share price.

Second Sight Medical Products share price volatility

Over the last 12 months, Second Sight Medical Products's shares have ranged in value from as little as $0.72 up to $20. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Second Sight Medical Products's is 3.3487. This would suggest that Second Sight Medical Products's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Second Sight Medical Products overview

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California. .

Second Sight Medical Products in the news

There are no recent company news

Frequently asked questions

What percentage of Second Sight Medical Products is owned by insiders or institutions?
Currently 25.236% of Second Sight Medical Products shares are held by insiders and 18.24% by institutions.
How many people work for Second Sight Medical Products?
Latest data suggests 11 work at Second Sight Medical Products.
When does the fiscal year end for Second Sight Medical Products?
Second Sight Medical Products's fiscal year ends in December.
Where is Second Sight Medical Products based?
Second Sight Medical Products's address is: 13170 Telfair Avenue, Sylmar, CA, United States, 91342
What is Second Sight Medical Products's ISIN number?
Second Sight Medical Products's international securities identification number is: US81362J2096
What is Second Sight Medical Products's CUSIP number?
Second Sight Medical Products's Committee on Uniform Securities Identification Procedures number is: 81362J100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site